Today, Dec. 18, 2025, investors are weighing Tilray’s fresh U.S. medical push and sector volatility after federal cannabis rescheduling.

President Donald Trump on Thursday signed an executive order asking the U.S. government to reschedule cannabis, a move that marks the most significant federal reform on the substance in decades, ...

Tilray Medical, a division of Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical ...

President Trump signed off on a move that could reschedule cannabis in the U.S. President Donald Trump on Thursday signed an executive order asking the U.S. government to reschedule cannabis - a move ...

Cannabis stocks such as Canopy Growth (CGC), Tilray Brands (TLRY), and Cronos Group (CRON) are up sharply on Dec. 18 after ...

Yahoo Finance host Josh Lipton tracks today's top moving stocks and biggest market stories in this Market Minute, including ...

Jim Cramer, the host of Mad Money, said on Tuesday that he believes the recent shift of money out of artificial intelligence ...

Summary • Tilray Brands, Inc. (TLRY) shares declined 2.7% to $13.57 in intraday trading amid routine activity.• The company ...

Tilray stock surged after reports Trump may reclassify marijuana to Schedule III. Is the rally sustainable or just speculative momentum?

Shares of Tilray Brands ($TLRY) moved back into positive territory after slipping earlier this week. The latest swings came ...

Tilray Brands stock jumped 27.5% on December 16 following Trump's marijuana reclassification comments and analyst upgrades.

Tilray Brands shares are in the spotlight Tuesday, surging over 20% amid continued chatter about potential marijuana ...